Colchicine review finds fewer major cardiovascular events, without a clear mortality difference
A synthesis of randomized trials examined colchicine for people with existing cardiovascular disease, including whether cumulative exposure shaped the results.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
Across trials in people with existing cardiovascular disease, colchicine reduced the odds of major adverse cardiovascular events. The review did not find differences in cardiovascular or non-cardiovascular mortality. Its cumulative-exposure analysis suggested a threshold, but the abstract alone does not establish an optimal treatment amount or duration for an individual patient.
The abstract does not report absolute event rates, follow-up lengths, or detailed methods for the cumulative-exposure analysis. Those omissions limit assessment of benefit size and the proposed exposure threshold.
What researchers found
Major adverse cardiovascular events
Colchicine versus placebo or standard care during trial follow-up; follow-up lengths were not reported in the abstract.
Clinical events and laboratory changes
The primary outcome combined major adverse cardiovascular events. C-reactive protein also decreased, but that laboratory finding is separate from the clinical-event result and does not itself establish a survival benefit.
Interpreting cumulative exposure
The authors examined outcomes in relation to accumulated colchicine exposure and reported a threshold pattern. This abstract-based account cannot determine how that analysis separated treatment amount, treatment duration, and differences among the included trials.
The original publication
Colchicine for the Secondary Prevention of Cardiovascular Diseases: A Cumulative-Dose Meta-analysis of Randomized Controlled Trials including 31,397 Subjects Worldwide.
Li HY, Cheriyan J, Chan TK et al.
Am J Cardiovasc Drugs · 2026
- PubMed ID
- 40889093
- Record checked
Linked publication notices
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.